Call for Editors – ISCB Community Journal
ISCB is seeking scholars interested in serving as volunteer editors for the ISCB Community Journal. If you are interested, please submit your nomination using our online system. If you have a colleague who may enjoy serving as a volunteer editor for ISCB, please feel free to forward this information.
The primary responsibility of an editor will be to oversee the content on the ISCB Community Journal homepage. Editors will work with the conferences and have the final decision on the selection of conference editors and editorial board proposed by the conferences. Editors will supervise the conference referee process and ensure the quality standards of referee reports, editorial decision and published papers. Editors will help to promote the journal and to increase the number of conferences publishing in the journal. The ISCB Community Journal editors will work closely with F1000Research to keep improving the journal and make sure it is meeting the aims and objectives of the ISCB. Editors are appointed by the ISCB Board of Directors and will serve a three-year term* with the option to be renewed for one additional term.
Applicants must be a member of ISCB and have significant publishing and reviewing experience, and experience reviewing and working with conference paper and abstract submissions. Due to the high volume of applications, only accepted applicants will be contacted via email.
Be prepared to submit the following information:
Your name
Email address
Telephone
City, State, Country
Name of your institution
Department or Division
Website of institution
Your title or position
Your highest degree
Years of editing or peer review experience
Which journals do you currently serve (List of Journals and specific role)?
Which conferences have you supported the review of submissions or program decisions?
Statement of interest that further support your nomination (cannot exceed 50 words).
Up to one page CV
*Terms will be staggered to ensure continuity for the journal. First year editors are not guaranteed a full three-year term.
2014 ISCB Fellows Keynote
Russ B. Altman, MD, PhD
Professor of Bioengineering, Genetics, and Medicine and Computer Science
Director, Biomedical Informatics Training Program
Stanford University, United States
website: http://helix-web.stanford.edu/people/altman/
Presentation Title: Informatics for understanding drug response at all scales
Presentation Time: Tuesday July 15, 4:40 pm - 5:40 pm
Introduction by: Reinhard Schneider, ISCB Treasurer
Abstract:
An understanding of drug action at multiple levels is required for optimal use of existing drugs, as well as for identifying new opportunities for therapeutics. Unlike many experimental programs, informatics programs for drug action can integrate data of length scales across length scales spanning more than 6 orders of magnitude: from molecular to global populations. In this talk, I will discuss how we have developed methods at the molecular, cellular, individual organism and population to understand drug response phenotypes, and the underlying molecular mechanism of these responses. This information can be used for understanding personalized medicine (pharmacogenomics), drug interactions, drug repurposing and druggability of orphan genes.
Biography
Russ Biagio Altman is a professor of bioengineering, genetics, & medicine (and of computer science, by courtesy) and past chairman of the Bioengineering Department at Stanford University. His primary research interests are in the application of computing and informatics technologies to basic biological problems relevant to medicine. He is particularly interested in methods for understanding drug action at molecular, cellular, organism and population levels. His lab studies how human genetic variation impacts drug response (e.g. http://www.pharmgkb.org/). Other work focuses on the analysis of biological molecules to understand the action, interaction and adverse events of drugs (http://features.stanford.edu/). He leads one of seven NIH-supported National Centers for Biomedical Computation, focusing on physics-based simulation of biological structures (http://simbios.stanford.edu/). Dr. Altman holds an A.B. from Harvard College, and M.D. from Stanford Medical School, and a Ph.D. in Medical Information Sciences from Stanford. He received the U.S. Presidential Early Career Award for Scientists and Engineers and a National Science Foundation CAREER Award. He is a fellow of the American College of Physicians, the American College of Medical Informatics, and the American Institute of Medical and Biological Engineering. He is a member of the Institute of Medicine of the National Academies. He is a past-president, founding board member, and a Fellow of the International Society for Computational Biology, and the President-Elect of the American Society for Clinical Pharmacology & Therapeutics. He currently chairs the Science Board advising the FDA Commissioner. He is an organizer of the annual Pacific Symposium on Biocomputing (http://psb.stanford.edu/), and a founder of Personalis, Inc. He won the Stanford Medical School graduate teaching award in 2000.
Welcome to the seventh annual Rocky Mountain Bioinformatics Conference, a meeting of the International Society for Computational Biology (ISCB). The organizers hope that you enjoy the program, and find the conference a productive opportunity to meet researchers, students and industrial users of bioinformatics technology. We think we have the best program yet, offering a remarkable cross-section of bioinformatics research.
The Rocky series began seven years ago as a regional conference, and has grown into an international program with a spotlight on regional development in the computational biosciences. The presenters of the Rocky conference are scientists representing a broad spectrum of universities, industrial enterprises, government laboratories, and medical libraries from around the world. The meeting is a chance to get to know your colleagues near and far, seek collaborative opportunities, and find synergies that can drive our field forward.
For 2009 we will continue with the changes made in 2008 with extending the meeting to three full days, keeping the short talks to 10 minutes, and keeping with a larger poster session, allowing everyone who wants to present to do so. And we've retained the lunchtime ski breaks so that those of you who want to ski, including beginners, will have a chance to do so among friends and colleagues.
We hope you enjoy the science, the company, and the spectacular scenery of the Rocky Mountains. Welcome!
Larry Hunter
Rocky '09 Conference Chair

Rocky '08 Comments
- 100% of the delegates found the conference met or exceeded their expectations
- 100% of the delegates found the conference was fair/good value
- 90% of the delegates said they would attend again
- “This was my first time attending the meeting. I was very dubious about the 10 minute talks. I was completely wrong. The talks were great. The conference was very well organized.”
- “As a primarily wet lab biologists. I did not have the necessary math/cs background, but I learned about many ideas”
- “As always, wonderful meeting in a great location. It is an excellent mix of different areas of science and a great way to meet new people. See you next year too.”
- “I have attended Rocky several times and I always learn something valuable.”
- “This has been a great conference. I look forward to attending next year.”
[TOP]
American Recovery and Reinvestment Act of 2009 includes New NIH Challenge Grants in Health and Science Research
The February 20, 2009 issue of the FASEB Washington Update newsletter includes information on the following of note for ISCB members interested in applying for new NIH grant funding availability:
NIH is designating at least $200 million of the funds it received from the American Recovery and Reinvestment Act of 2009 (the “stimulus bill”) in FYs 2009 - 2010 for a new initiative called the NIH Challenge Grants in Health and Science Research. The new program is expected to fund 200 or more grants, contingent upon the submission of a sufficient number of scientifically meritorious applications. This program will support research on 15 high priority topics within broad challenge areas that address specific scientific and health research challenges in biomedical and behavioral research that will benefit from significant 2-year jumpstart funds. Challenge Areas, defined by the NIH, focus on specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways. The research in these areas should have a high impact in biomedical or behavioral science and/or public health. The NIH Challenge Grant information is now live on the NIH Web site at http://grants.nih.gov/grants/funding/challenge_award/. Please note that the RFA includes the following important deadlines:
- Release/Posted Date: March 4, 2009
- Opening Date: March 27, 2009 (Earliest date an application may be submitted to Grants.gov)
- Letters of Intent Receipt Date(s): Not applicable
- NOTE: On-time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization).
- Application Due Date(s): April 27, 2009
- Peer Review Date(s): June/July 2009
- Council Review Date(s): August 2009
- Earliest Anticipated Start Date(s): September 30, 2009
- Additional Information To Be Available Date (Activation Date): Not Applicable
- Expiration Date: April 28, 2009
TOP
Participate in ISCB Blogs on Hot Topics for Bioinformaticians
Share your thoughts!
ISCB is committed to advancing our science to the benefit of our members and the broader bioinformatics community, who in turn are committed to the improvement of human health. As such, we are seeking community input on hot topics that impact the way we work, learn and network. Become an ISCB blogger on the following topics, and be sure to return often (or set up an RSS feed) to see if your fellow bloggers agree, disagree or have shed some light on a different angle that might be of benefit to you as you tackle these issues yourself.
SRS3D now freely available
SRS 3D is a module of Biowisdom's SRS system that enables the integration and display of sequences and annotations together with 3D structures. The details are available at http://www.SRS3D.org, a site hosted by the European Molecular Biology Laboratory (EMBL).